| Primary |
| Hypertension |
57.6% |
| Hyperlipidaemia |
5.7% |
| Aortic Dissection |
3.8% |
| Insomnia |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Cardiac Failure Congestive |
2.5% |
| Diabetes Mellitus |
2.5% |
| Prophylaxis |
2.5% |
| Affective Disorder |
1.9% |
| Gastritis |
1.9% |
| Hypertensive Heart Disease |
1.9% |
| Hyperuricaemia |
1.9% |
| Osteoarthritis |
1.9% |
| Osteoporosis |
1.9% |
| Anxiety Disorder |
1.3% |
| Atrial Fibrillation |
1.3% |
| Cerebral Infarction |
1.3% |
| Constipation |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Iron Deficiency Anaemia |
1.3% |
|
| Hyponatraemia |
10.0% |
| Cerebral Infarction |
7.5% |
| Completed Suicide |
7.5% |
| Interstitial Lung Disease |
7.5% |
| Renal Failure Chronic |
7.5% |
| Abortion Induced |
5.0% |
| Brain Natriuretic Peptide Increased |
5.0% |
| Eosinophilic Pneumonia |
5.0% |
| False Positive Laboratory Result |
5.0% |
| Hyperkalaemia |
5.0% |
| Nausea |
5.0% |
| No Adverse Event |
5.0% |
| Platelet Count Decreased |
5.0% |
| Rhinitis Allergic |
5.0% |
| Asthenia |
2.5% |
| Blood Creatine Phosphokinase Increased |
2.5% |
| Cellulitis |
2.5% |
| Cholangitis Acute |
2.5% |
| Contrast Media Reaction |
2.5% |
| Contusion |
2.5% |
|
| Secondary |
| Hypertension |
34.1% |
| Product Used For Unknown Indication |
12.6% |
| Depression |
7.4% |
| Aortic Dissection |
4.4% |
| Cerebral Infarction |
4.4% |
| Reflux Oesophagitis |
4.4% |
| Pain |
3.7% |
| Angina Pectoris |
3.0% |
| Hypercholesterolaemia |
3.0% |
| Partial Seizures |
3.0% |
| Sleep Disorder |
3.0% |
| Type 2 Diabetes Mellitus |
3.0% |
| Cardiac Failure |
2.2% |
| Hyperuricaemia |
2.2% |
| Insomnia |
2.2% |
| Anxiety |
1.5% |
| Behavioural And Psychiatric Symptoms Of Dementia |
1.5% |
| Cerebrovascular Accident |
1.5% |
| Constipation |
1.5% |
| Dyslipidaemia |
1.5% |
|
| Hyponatraemia |
19.4% |
| Dehydration |
6.5% |
| False Positive Laboratory Result |
6.5% |
| Nausea |
6.5% |
| Nephropathy |
6.5% |
| Pancreatitis Acute |
6.5% |
| Rhabdomyolysis |
6.5% |
| Adverse Drug Reaction |
3.2% |
| Areflexia |
3.2% |
| Atrioventricular Block Complete |
3.2% |
| Blood Creatine Phosphokinase Increased |
3.2% |
| Bronchopulmonary Aspergillosis |
3.2% |
| Cellulitis |
3.2% |
| Completed Suicide |
3.2% |
| Dermatitis Exfoliative |
3.2% |
| Gastric Atony |
3.2% |
| Haematuria |
3.2% |
| Hypertensive Crisis |
3.2% |
| Loss Of Consciousness |
3.2% |
| Petechiae |
3.2% |
|
| Concomitant |
| Hypertension |
39.3% |
| Rheumatoid Arthritis |
12.5% |
| Product Used For Unknown Indication |
6.6% |
| Diabetes Mellitus |
5.4% |
| Prophylaxis |
5.4% |
| Cerebral Infarction |
3.5% |
| Pain |
3.1% |
| Relapsing-remitting Multiple Sclerosis |
2.7% |
| Latent Tuberculosis |
2.3% |
| Mineral Supplementation |
2.3% |
| Atrial Fibrillation |
1.9% |
| Hepatic Neoplasm Malignant |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Abdominal Pain Upper |
1.6% |
| Arthritis |
1.6% |
| Blood Potassium Decreased |
1.6% |
| Cardiac Failure |
1.6% |
| Crystal Arthropathy |
1.6% |
| Dyslipidaemia |
1.6% |
| Micturition Disorder |
1.6% |
|
| Renal Impairment |
7.7% |
| Abortion Induced |
5.1% |
| Atrioventricular Block Second Degree |
5.1% |
| Burning Sensation |
5.1% |
| Chest Pain |
5.1% |
| Cytomegalovirus Enterocolitis |
5.1% |
| Dizziness |
5.1% |
| Drug Interaction |
5.1% |
| Glomus Tumour |
5.1% |
| Hypoglycaemic Coma |
5.1% |
| Interstitial Lung Disease |
5.1% |
| Lung Adenocarcinoma Metastatic |
5.1% |
| Myocardial Infarction |
5.1% |
| Night Sweats |
5.1% |
| Oedema Peripheral |
5.1% |
| Peripheral Coldness |
5.1% |
| Pyrexia |
5.1% |
| Urticaria |
5.1% |
| Anaemia |
2.6% |
| Angiopathy |
2.6% |
|
| Interacting |
| Hypertensive Heart Disease |
31.6% |
| Osteoarthritis |
21.1% |
| Depression |
10.5% |
| Hypertension |
10.5% |
| Pulmonary Embolism |
10.5% |
| Pulmonary Hypertension |
10.5% |
| Ischaemic Heart Disease Prophylaxis |
5.3% |
|
| Hypotension |
33.3% |
| Right Ventricular Failure |
33.3% |
| Therapeutic Agent Toxicity |
33.3% |
|
